Jennifer McNeely, MD, MS
Associate Professor, NYU Grossman School of Medicine
Section on Tobacco, Alcohol, and Drug Use (TADU)
This is a phased feasibility and proof-of-concept study seeking to incorporate addiction-specific screening and assessment CDEs into a widely used EHR, explore the logistics and time required to do this, and assess impacts on the frequency of identification, diagnosis and referral to treatment in large healthcare organizations.
In this quality improvement study implementing systematic screening for alcohol and drug use among 93,114 patients in 6 primary care clinics, 72% of patients completed screening. Screening at any visit (in comparison with screening at annual examinations only) was associated with higher screening rates for alcohol and drug use, and self-administered screening was associated with greater detection of moderate- to high-risk alcohol use compared with staff-administered screening.
Primary Outcomes Article: McNeely J, et al. Comparison of Methods for Alcohol and Drug Screening in Primary Care Clinics. JAMA Network Open 2021;4(5):e2110721. [get article]
- CTN-0062-Ot-A-1: Implementing the Tobacco, Alcohol, Prescription Medication, and Other Substances (TAPS) Tool in Rural Federally-Qualified Health Centers
All Participating Nodes: